These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25550416)

  • 1. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.
    Rooney J; Byrne S; Heverin M; Tobin K; Dick A; Donaghy C; Hardiman O
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):496-501. PubMed ID: 25550416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1258-61. PubMed ID: 12933930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study.
    Galvin M; Madden C; Maguire S; Heverin M; Vajda A; Staines A; Hardiman O
    BMC Health Serv Res; 2015 Dec; 15():571. PubMed ID: 26700026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.
    Turner MR; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):481-2. PubMed ID: 25550412
    [No Abstract]   [Full Text] [Related]  

  • 5. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G
    J Neurol; 2007 Aug; 254(8):1107-12. PubMed ID: 17431705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.
    O'Toole O; Traynor BJ; Brennan P; Sheehan C; Frost E; Corr B; Hardiman O
    J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):30-2. PubMed ID: 17634215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The patient's opinion matters: experience in the nutritional care in an ALS multidisciplinary team].
    Jiménez García I; Sala Moya N; Riera Munt M; Herrera Rodríguez MV; Povedano Panadés M; Virgili Casas MN
    Nutr Hosp; 2015 May; 31 Suppl 5():56-66. PubMed ID: 25938606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of cost of care at multidisciplinary ALS centers adhering to American Academy of Neurology (AAN) ALS practice parameters.
    Boylan K; Levine T; Lomen-Hoerth C; Lyon M; Maginnis K; Callas P; Gaspari C; Tandan R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):119-27. PubMed ID: 26462131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center.
    Klavžar P; Koritnik B; Leonardis L; Dolenc Grošelj L; Kirbiš M; Ristić Kovačič S; Klinar P; Pohar Perme M; Zidar J
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):203-208. PubMed ID: 32248716
    [No Abstract]   [Full Text] [Related]  

  • 11. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.
    Martin S; Trevor-Jones E; Khan S; Shaw K; Marchment D; Kulka A; Ellis CE; Burman R; Turner MR; Carroll L; Mursaleen L; Leigh PN; Shaw CE; Pearce N; Stahl D; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):569-575. PubMed ID: 28719997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021.
    McFarlane R; Peelo C; Galvin M; Heverin M; Hardiman O
    Neurology; 2023 Nov; 101(19):e1905-e1912. PubMed ID: 37748881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and social care costs of managing amyotrophic lateral sclerosis (ALS): an Irish perspective.
    Connolly S; Heslin C; Mays I; Corr B; Normand C; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):58-62. PubMed ID: 25285902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis of geospatial factors in the Irish ALS cohort.
    Rooney J; Heverin M; Vajda A; Burke T; Galvin M; Tobin K; Elamin M; Staines A; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):555-560. PubMed ID: 27145090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital infection society prevalence survey of Healthcare Associated Infection 2006: comparison of results between Northern Ireland and the Republic of Ireland.
    Fitzpatrick F; McIlvenny G; Oza A; Newcombe RG; Humphreys H; Cunney R; Murphy N; Ruddy R; Reid G; Bailie R; Lavelle C; Doherty L; Smyth ET
    J Hosp Infect; 2008 Jul; 69(3):265-73. PubMed ID: 18547678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.
    Traynor BJ; Codd MB; Corr B; Forde C; Frost E; Hardiman O
    Neurology; 1999 Feb; 52(3):504-9. PubMed ID: 10025778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis.
    Byrne S; Heverin M; Elamin M; Bede P; Lynch C; Kenna K; MacLaughlin R; Walsh C; Al Chalabi A; Hardiman O
    Ann Neurol; 2013 Nov; 74(5):699-708. PubMed ID: 23836460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations.
    Ryan M; Zaldívar Vaillant T; McLaughlin RL; Doherty MA; Rooney J; Heverin M; Gutierrez J; Lara-Fernández GE; Pita Rodríguez M; Hackembruch J; Perna A; Vazquez MC; Musio M; Ketzoian CN; Logroscino G; Hardiman O
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):659-665. PubMed ID: 30846540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.
    Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.